412 filings
8-K
EYPT
EyePoint Pharmaceuticals Inc
7 Mar 24
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
4 Mar 24
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
7:01am
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 Jan 24
Results of Operations and Financial Condition
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
8 Dec 23
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:02pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
7 Dec 23
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
6:11pm
8-K
1z18d
4 Dec 23
Other Events
7:05am
8-K
75r1phwaogulckx
9 Nov 23
Other Events
8:00am
8-K
w4dk5
1 Nov 23
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
nsn1j
16 Oct 23
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
7:05am
8-K
ea57tbyd eirof
13 Sep 23
Other Events
7:06am
8-K
6vw5gmo
11 Sep 23
Other Events
7:05am
8-K
ibv5uxg sb3
2 Aug 23
EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
nk2jgg7p8
27 Jul 23
Other Events
4:06pm
8-K
ol5b7kp3
11 Jul 23
Other Events
7:06am
8-K
rcmlum x4
10 Jul 23
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
7:05am
8-K
bp4bt plr
21 Jun 23
Departure of Directors or Certain Officers
7:53am
8-K
lqeraz e2d
5 Jun 23
EyePoint Pharmaceuticals Completes Enrollment in Phase 2 PAVIA Clinical Trial of EYP-1901 in Non-Proliferative Diabetic Retinopathy
7:06am
8-K/A
ym9257m67
23 May 23
Financial Statements and Exhibits
5:24pm
8-K
oiqyrnvstm5jj0r7n0k9
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
8-K
almvng
3 May 23
EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am